Bonnie Feldman, DDS, MBA

Portfolia is the most powerful community of women and men investing in the companies we want in the world. Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity. Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity. We drive change while creating wealth. If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.

We invest in companies advancing better autoimmune and immune-mediated care across diagnostics, therapeutics, devices, digital health, and care models. We focus on the convergence of precision immunology, longevity science, and women’s health to enable disease-modifying, personalized, and preventative solutions. Contact: bonnie@autoimmune.fund

Founded in 2014, we’re America’s largest venture firm for individual investors and VC investing partner to over 11,000 individuals and institutions. Offerings include institutional-grade funds with large diversified portfolios and deal-by-deal investing through our Syndicates. Investment minimum is $10,000. • Top-20 VC Firm (Time Magazine ’25) • Top-Decile Investment Performance (Carta Benchmarks ‘25) • Top 20 VC Firm (CB Insights 24) • Top 50 Unicorn VC (Stanford GSB Research ‘25) • Top 3 Most Active US VC Firm (PitchBook ‘18 - ‘24) • Most Founder Friendly Investor List (Inc. Magazine ‘24) • Worlds Most Innovative Companies (Fast Company 22) • #1 Most Active Venture Firm in the US (PitchBook 22 & 23) • Top 20 Venture Firm (CB Insights 24) • Worlds Most Innovative Companies (Fast Company 22) • Portfolio of 1,600+ current and historical companies • 40+ full-time VC investors • Founders get access to our community of 850,000+ members and 6,000+ Experts. Offers of securities made only to eligible investors by formal offering documents describing risks, terms, and other important information that must be considered before investing. Example portfolio companies shown for illustrative purposes only, do not necessarily reflect investment outcomes that were or would be obtained by any AV fund or investor, and are not available to future investors, except potentially in follow-on investments. Venture capital investing involves substantial risk, including risk of loss of all capital invested. Past performance does not guarantee future results. The content on this account is intended solely for persons located in the U.S. and is not directed at, and must not be acted upon, by any person in the United Kingdom. UK residents seeking information about AV should refer only to communications issued by Alumni Ventures UK LLP, which provides information solely on a non-promotional basis and only distributes Financial Promotions to eligible recipients in accordance with UK law.

Portfolia is the most powerful community of women and men investing in the companies we want in the world. Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity. Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity. We drive change while creating wealth. If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.

We provide professional services to investors that share our vision of delivering better healthcare at lower costs to people with autoimmune & other chronic diseases. We help our clients advance virtual-first, digitally coordinated, patient-centered care across the spectrum of autoimmune and chronic immuno-inflammatory disorders. We approach all projects from a foundation of decades of experience in multiple areas of expertise. Experience includes start-up co-founder (Yashi Care), practicing dentist, business & financial analyst, corporate & marketing communications, educated patient & advocate. SME: Autoimmune & immuno-inflammatory disease Virtual-first, patient-centric care coordination & delivery Lifestyle, functional & integrative modalities Long covid & other post-viral syndromes Oral & gut microbiome connection to systemic disease Corporate & marketing communications Biopharma/biotech, medical devices, healthcare IT Our professional services include: Autoimmune early stage investing & due diligence Patient-centric care informed by patient advocacy Financial background: Wall Street sell-side, buy-side, & investor relations professional. Digital health, virtual-first, biotech, pharma & medical device consulting. Our interest & expertise spans across healthcare silos, so necessary to improve autoimmune care. How can we help you? Contact me for a free assessment of your needs & discussion of our capabilities.

Rheumission is a virtual-first integrative rheumatology and lifestyle medicine practice that provides people with rheumatology conditions fast access to personalized care. Autoimmune patient-doctors developed our first-of-its kind, evidence-based program. Our multi-disciplinary care team includes a triple board-certified rheumatologist, double board-certified lifestyle medicine doctor, autoimmune registered dietitian, PhD psychologist/therapist, and care coordinators, plus an app to keep all your records and tracking in one place. An actuarial analysis of our model resulted in 65% remission rates and $16,444 in cost savings. Our mission is remission!